LBA23MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC)
Tolaney, S M, Wardley, A M, Zambelli, S, Hilton, J, Troso-Sandoval, T, Ricci, F, Im, S-A, Kim, S-B, Johnston, S R D, Chan, A, Goel, S, Catron, K, Yang, Z, Gainford, C, André, FVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz394.012
Date:
October, 2019
File:
PDF, 85 KB
english, 2019
File converter
More search results
More benefits 
